Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID07265037

Development of a New Integrated Strategy for Long-Distance and Full-Course Management of Diabetes Using Both Traditional Chinese and Western Medicine: A Combined Online and Offline Approach

Led by Shanxi Bethune Hospital · Updated on 2025-12-04

10000

Participants Needed

1

Research Sites

13 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating a new integrated strategy combining Traditional Chinese Medicine (TCM) and Western Medicine to manage type 2 diabetes. The study aims to create an efficient, personalized, and intelligent long-distance management system that reduces diabetes complications and improves patients' quality of life. This approach addresses current challenges in diabetes care in China, such as high costs and low efficiency, by blending the strengths of both medical traditions and using digital health technologies. Participants will be assigned to one of two groups. One group will use an innovative smart platform that includes connected devices, a mobile app, and cloud services to support diabetes management. This platform offers personalized assessments based on TCM and Western medical data, automated reminders for glucose monitoring, medication, and lifestyle, and access to a multidisciplinary expert team online. The management plan is updated every three months with ongoing data analysis. The other group will receive standard diabetes care, including regular endocrinologist visits, medication, and routine education, without access to the smart platform or personalized remote support. Participants will be monitored for six months, with evaluations including blood tests for glycated hemoglobin (HbA1c) and blood glucose levels to assess diabetes control. Researchers will track how often participants maintain their blood glucose within target ranges and the rate of achieving glycemic goals. The study involves continuous remote monitoring, regular follow-ups, and use of digital tools to support adherence. The total participation time for outcome measurement is six months, focusing on improving long-term diabetes management through integrated care.

CONDITIONS

Brief Title

Integrated TCM - Western Medicine Strategy for Long - Distance Diabetes Management

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged 18 years or older
  • Presence of typical diabetes symptoms such as frequent urination, excessive thirst, increased hunger, or unexplained weight loss
  • Confirmed diabetes diagnosis by laboratory tests: fasting venous plasma glucose ≥ 7.0 mmol/L, or random plasma glucose ≥ 11.1 mmol/L, or glycated hemoglobin (HbA1c) ≥ 6.5%
  • Alternatively, meeting oral glucose tolerance test criteria: fasting plasma glucose ≥ 7.0 mmol/L and 2-hour plasma glucose ≥ 11.1 mmol/L after a 75g glucose load
Not Eligible

You will not qualify if you...

  • Having serious health conditions that may prevent following the study protocol, including active cancer
  • Presence of rheumatic autoimmune diseases
  • Having severe infections
  • Experiencing multiple organ failure
  • Having psychiatric disorders

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person or remote) for eligibility assessment

Treatment

Duration - 6 months

Participants receive either the integrated TCM-Western Medicine smart diabetes management via a connected platform including devices, app, and remote expert support, or conventional diabetes care with standard outpatient follow-ups and pharmacological therapy.

Regular monitoring and follow-up visits as per assigned care pathway, typically including quarterly assessments

Trial Site Locations

Total: 1 location

1

Shanxi Bethune Hospital

Taiyuan, Shanxi, China, 030000

Actively Recruiting

Loading map...

Research Team

S

Shiwei Liu, Doctor

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

HEALTH_SERVICES_RESEARCH

Number of Arms

2

Similar Trials

24-hour Movement Behaviors Among Adults with Type 2 Diabetes...

Diabetes Mellitus, Type 2

Actively Recruiting

1 location

A Multiple Dose Clinical Study to Evaluate the Safety, Toler...

Diabetes Mellitus, Type 2

Actively Recruiting

4 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here